Siemens Healthineers clears Jefferies Buy call, shares trade in the DAX healthcare segment
25.06.2026 - 19:52:47 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-25, 19:52.
Siemens Healthineers (DE000SHL1006) stays on the radar of international brokerages, with Jefferies reiterating its Buy stance and a 50 euro price target after fresh preliminary statements from the medtech group, as carried by dpa-AFX. The stock is listed in the DAX and TecDAX and trades on Xetra in euros.
What Jefferies is telling clients
According to a note summarized by dpa-AFX this morning, Jefferies leaves its rating on Siemens Healthineers unchanged at Buy and confirms a target price of 50 euros per share. The New York based house refers to early comments by the company ahead of upcoming detailed figures and underlines the longer term structural demand in imaging and diagnostics.
The analysts highlight that Siemens Healthineers continues to operate with a broad installed base in diagnostic imaging and laboratory equipment, and they see room for margin improvement as service and software grow as a share of revenues. Jefferies points out the group’s exposure to secular trends in healthcare spending and demographic aging, which it expects to support the earnings trajectory.
How the consensus is lining up
Beyond Jefferies, Siemens Healthineers is covered by a broad set of houses, with data aggregators showing a majority of Buy recommendations and only a minority of Hold or Sell ratings. MarketScreener and similar platforms list the shares in the DAX and TecDAX, with consensus price targets notably above the current market level.
On vista type portals, Siemens Healthineers is categorized under medical devices, with the WKN SHL100 and ticker SHL used across German venues. The shares are part of the Prime Standard segment in Frankfurt, anchoring the stock firmly within the German blue chip and technology indices.
All news and analysis on the Siemens Healthineers shares
For a broader picture of Siemens Healthineers, including previous analyst updates, price data and regulatory filings, the ad-hoc-news topic page and the company’s Investor Relations section provide structured access.
The product behind the stock
Siemens Healthineers generates much of its revenue from diagnostic imaging systems such as magnetic resonance imaging scanners, as well as computed tomography and X-ray equipment used by hospitals worldwide. Alongside hardware, the group sells software and digital platforms that help clinicians interpret images and manage workflows.
Where the stock trades today
The Siemens Healthineers shares (DE000SHL1006) trade on Xetra at around 34.07 to 34.42 euros in late Frankfurt indication on 2026-06-25, with recent dpa-AFX quotes marking the bid and ask levels in the evening session.
Key data on the Siemens Healthineers shares
- Company: Siemens Healthineers AG
- ISIN: DE000SHL1006
- WKN: SHL100
- Ticker: SHL
- Trading venue: Xetra
- Price (as of 2026-06-25, 19:02): 34.07/34.42 euros (bid/ask)
- Market cap: around 38 billion euros (as of 2026-06-25, based on Xetra level and latest share count).
- Sector / industry: Healthcare equipment & supplies
- Index membership: DAX, TecDAX, STOXX Europe 600
- Next earnings date: not officially scheduled
Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. All data are based on sources believed to be reliable at the time of publication, without any guarantee of completeness or accuracy.
